CENTAMEDIUM SIGNALFINANCIAL10-K

Central Garden & Pet delivered substantially higher net income and solid operating income growth while simplifying its market positioning language from dual "pet and garden industries" to broader "market leader in the U.S."

The strong earnings performance suggests operational improvements and effective cost management, though the decline in operating cash flow warrants monitoring as it may indicate working capital changes or timing differences. The simplified market positioning language could signal strategic focus changes or preparation for business model evolution.

Comparing 2025-11-26 vs 2024-11-27View on EDGAR →
FINANCIAL ANALYSIS

Central Garden & Pet demonstrated strong profitability with substantially higher net income and solid operating income growth of 35%. However, operating cash flow declined by 16% despite the earnings strength, creating a disconnect that suggests potential working capital investments or timing issues. The company maintained a solid cash position with $882.5M in cash and equivalents, providing financial flexibility.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+50.8%
$108.0M$162.8M

Net income grew 50.8% — bottom-line growth signals improving overall business health.

Operating Income
P&L
+34.9%
$185.4M$250.0M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Cash & Equivalents
Balance Sheet
+17.1%
$753.5M$882.5M

Cash grew 17.1% — improving liquidity position supports investment and shareholder returns.

Operating Cash Flow
Cash Flow
-15.8%
$394.9M$332.5M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

LANGUAGE CHANGES
NEW — 2025-11-26
PRIOR — 2024-11-27
ADDED
Form 10-K Summary 34 i FORWARD-LOOKING STATEMENTS This Form 10-K includes forward-looking statements.
MARKET, RANKING AND OTHER DATA The data included in this Form 10-K regarding markets and ranking, including the size of certain markets and our position and the position of our competitors and products within these markets, are based on both independent industry publications, including National Gardening Survey, July 10, 2025; The Freedonia Group U.S.
Lawn and Garden Consumables, November 2025; Packaged Facts U.S.
Pet Market Outlook, 2025-2026; American Pet Products Association (APPA) National Pet Owners Survey 2025; IBIS World Industry Report Pet Stores in the U.S., September 2025; U.S.
Business Our Company Central Garden Pet Company ( Central ) is a market leader in the U.S.
+7 more — sign up free →
REMOVED
Form 10-K Summary 37 i FORWARD-LOOKING STATEMENTS This Form 10-K includes forward-looking statements.
MARKET, RANKING AND OTHER DATA The data included in this Form 10-K regarding markets and ranking, including the size of certain markets and our position and the position of our competitors and products within these markets, are based on both independent industry publications, including The Freedonia Group Lawn Care Consumer Insights, October 2022; National Gardening Survey, April 2023; The Freedonia Group Outdoor Living Products, June 2023; Packaged Facts Lawn and Garden Consumables, December 2022; Packaged Facts U.S.
Pet Market Outlook, 2023-2024, April 2023; Packaged Facts Pet Market Sizing Spreadsheet, August 2023; Packaged Facts Pet Stores and Pet Specialty Retailing, January 23; Packaged Facts Durable Dog and Cat Pet Care Products, May 2022; American Pet Products Association (APPA) National Pet Owners Survey 2023-24; IBIS World Industry Report 45391 Pet Stores in the U.S., April 2019; U.S.
Business Our Company Central Garden Pet Company ( Central ) is a market leader in the pet and garden industries in the United States.
For over 40 years, Central has marketed innovative and trusted solutions helping lawns grow greener, gardens bloom bigger, pets live healthier, and communities grow stronger.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →